Market Closed -
OTC Markets
01:26:09 04/05/2024 am IST
5-day change
1st Jan Change
0.00055
USD
+10.00%
+20.00%
+20.00%
Sales 2022
0.02
1.43
Sales 2023
0.03
2.38
Capitalization
448K
37.37M
Net income 2022
-
0
Net income 2023
-
0
EV / Sales 2022
3,01,65,231
x
Net Debt
2022
367K
30.58M
Net Debt
2023
268K
22.39M
EV / Sales 2023
2,50,75,337
x P/E ratio 2022
-0.07
x
P/E ratio 2023
-0.39
x
Employees
5
Yield 2022 *
-
Yield 2023
-
Free-Float
99.77%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
10/04
CI
Bioadaptives, Inc. Announces Naturacomplete?, an All-In-One Supplement to Optimize Its Ai-Based FYO Obesity Management System
22/02
CI
BioAdaptives Announces Signing of a New Distributor?s Agreement for AI Body Composition Measuring App and New Weight Management System
17/01
CI
BioAdaptives Inc. Announces the Development of PROTEINnMORETM
14/12
CI
BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula
16/11
CI
BioAdaptives, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
14/11
CI
BioAdaptives, Inc. Highlights Continued Success of Popular LUNG ARMOR System as US Enters Flu Season
09/11
CI
BioAdaptives, Inc. Announces Nationwide Launch of Lung Fortress Natural Supplement
10/23/10
CI
BioAdaptives, Inc. Commences Development of A New Supplement for Women?S Health
05/23/05
CI
BioAdaptives, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
12/23/12
CI
BioAdaptives, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
12/23/12
CI
BioAdaptives, Inc. Announces the Appointment of David Allen to its Board of Directors
13/23/13
CI
BioAdaptives, Inc. Signs Non-Exclusive Marketing Agreement with World Wellness, LLC
06/23/06
CI
BioAdaptives, Inc. Announces the Appointment of Dr. Yaguang Liu to its Board of Directors
05/23/05
CI
BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
01/23/01
CI
More news
BioAdaptives, Inc. Announces NaturaComplete™, an All-In-One Supplement to Optimize Its AI-Based FYO Obesity Management System
22/02
AQ
BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management
01/02
AQ
BioAdaptives Announces Signing of a New Distributor’s Agreement for AI Body Composition Measuring App and New Weight Management System
17/01
AQ
Livestock Impact, Inc., Subsidiary of BioAdaptives, Inc., Launches Innovative Food Lab for Development of Treats and Supplement Powder for Human, Equine, and Canine Products
04/01
AQ
BioAdaptives, Inc. to Form New Division, AI BodyShape Lab, to Promote Adult Fitness and Weight Management
21/12
AQ
More press releases
1 day +10.00%
1 week +20.00%
1 month +20.00%
3 months -40.00%
6 months -45.45%
Current year +20.00%
More quotes
Managers
Title Age Since
Chief Executive Officer
83
15/18/15
Director of Finance/CFO
82
11/19/11
Chief Operating Officer
78
31/21/31
Members of the board
Title Age Since
Chief Executive Officer
83
15/18/15
Director of Finance/CFO
82
11/19/11
Chief Operating Officer
78
31/21/31
More insiders
Date
Price
Change
Volume
03/24/03
0.00055
+10.00%
1,200,500
02/24/02
0.0005
0.00%
3,520,523
01/24/01
0.0005
-16.67%
18,610,394
30/24/30
0.0006
+9.09%
3,679,312
29/24/29
0.00055
+10.00%
47,356,920
Delayed Quote
OTC Markets, May 04, 2024 at 01:26 am IST
More quotes
BioAdaptives, Inc. manufactures and distributes natural plant and algal-based products that improve health and wellness for humans and animals, with an emphasis on optimizing pain relief, antiviral activity, and immune system defense; resistance to stress; endurance; recovery from injury, illness, and exercise; and anti-aging properties. Its products include dietary supplements using natural ingredients and proprietary methods of optimizing the availability of nutrients in foods and beverages. Its product line for humans includes PluriPain, PrimiLungs, SleepEZ, MindNMemory, Cell Rejuven and ProteinNMore. It also markets the Lung Flute and PrimiLungs products in its Lung Armor packaging, emphasizing the anti-viral properties of the nutraceutical and general respiratory health benefits from use of the device. Its animal products include an Equine All-in-One and Equine All-In-One Plus formulation, which it markets to trainers, horse owners and boarding stables, and a Canine All-in-One.
More about the company
1st Jan change
Capi.
+20.00% 677K +13.21% 8.15B +3.16% 7.52B +12.30% 6.65B -5.71% 3.73B -6.99% 3.72B -4.78% 1.31B +12.61% 972M -37.22% 958M -15.02% 876M
Special Foods & Wellbeing Products
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1